Intermittent PrEP may be a robust strategy for anal sex – vaginal much less certain
Non-daily PrEP regimens provide extra options, but adherence is often better with daily dosing
Black market for Truvada PrEP may undermine treatment adherence in marginalised people living with HIV
Transmitted HIV drug resistance is persistent but is not harming treatment responses in the UK
Truvada PrEP causes only mild loss of bone mineral density
Daily PrEP leads to better adherence and protective drug levels in women
Levels of maraviroc in vaginal and rectal tissues may not be high enough for pre-exposure prophylaxis
Combining PrEP and ART could almost eliminate HIV infection, east African study finds
Pre-exposure prophylaxis also stops 86% of HIV infections in Ipergay study
